EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Understanding Cancer Treatment Decision Making Among Cancer Survivors: Weighing Cancer Recurrence Versus Cardiotoxicity

Brennan P Streck, Jacqueline B Vo, Carolyn Brandt, William M P Klein, Paul Han iD, Rebecca A Ferrer, Arielle S Gillman

Psycho-Oncology · 2025

DOI: 10.1002/pon.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Brennan P Streck und 6 weiteren Autor:innen. Beteiligte Einrichtung: Basic Biobehavioral and Psychological Sciences Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Canc…. Hauptthemen laut MEDLINE: Decision Making, Neoplasms, Cardiotoxicity, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nearly 20% of US cancer survivors develop cardiovascular disease (CVD) from cardiotoxic cancer treatments. Patients and providers may consider alternative treatments to lower cardiotoxicity risk, but these may be less effective at preventing relapse/recurrence, presenting a difficult tradeoff.

Aims

This study explored survivors' cancer treatment decision‐making when weighing this tradeoff.

Methods

Using adjusted multivariable logistic regression, we examined 443 US survivors' risk perceptions (deliberative, affective, and intuitive) about cancer and CVD and associations of these with their selection between two hypothetical cancer treatments: Treatment A: 5% chance of cancer recurrence and 10% chance of CVD; Treatment B: 10% chance of recurrence and 5% chance of CVD. We explored the effects of delay discounting by randomizing to a condition describing cancer recurrence/CVD as either immediate or delayed.

Results

More survivors (Mage = 48, range = 18–93; M = 10.8 years post‐diagnosis) selected Treatment A than Treatment B ( 72% v. 28%) . Timing of onset was not associated with treatment selection. Greater affective risk perception (worry) about cancer was associated with increased odds of choosing Treatment A, whereas greater CVD worry was associated with decreased odds ( OR‐cancer = 1.33, p = 0.006; OR‐CVD = 0.72, p = 0.007). Neither deliberative nor experiential risk perceptions were associated with treatment choice.

Conclusions

Survivors were more likely to select the treatment that minimized recurrence rather than CVD—regardless of the timing of onset. Treatment decision was linked to both cancer‐ and CVD‐related worry but not deliberative or experiential risk perceptions. During treatment discussions, clinicians should open conversations about the risks of treatment‐associated cardiotoxicity, the probabilities, and patients' relative worries about cancer and cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision MakingNeoplasmsCardiotoxicityNeoplasm Recurrence, LocalCardiovascular DiseasesCancer SurvivorsSurvivorsHumansFemaleMaleMiddle AgedAgedAdultAged, 80 and overYoung AdultAdolescent

Stichwörter der Autor:innen

affective sciencecancerdecision makingneoplasmoncologypsycho‐oncologysurvivorship

Autor:innen und Institutionen

  • Basic Biobehavioral and Psychological Sciences Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA.
  • Radiation Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA.
  • Integrative Biological and Behavioral Sciences, Division of Extramural Scientific Programs, National Institute on Minority Health and Health Disparities, Rockville, Maryland, USA.

ORCID-Profile: Paul Han

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Streck, B. P., Vo, J. B., Brandt, C., Klein, W. M. P., Han, P., Ferrer, R. A., & Gillman, A. S. (2025). Understanding Cancer Treatment Decision Making Among Cancer Survivors: Weighing Cancer Recurrence Versus Cardiotoxicity. Psycho-Oncology. https://doi.org/10.1002/pon.70061

Vancouver

Streck BP, Vo JB, Brandt C, Klein WMP, Han P, Ferrer RA, et al. Understanding Cancer Treatment Decision Making Among Cancer Survivors: Weighing Cancer Recurrence Versus Cardiotoxicity. Psycho-Oncology. 2025. doi:10.1002/pon.70061

BibTeX
@article{Streck2025,
  author = {Streck, Brennan P and Vo, Jacqueline B and Brandt, Carolyn and Klein, William M P and Han, Paul and Ferrer, Rebecca A and Gillman, Arielle S},
  title = {Understanding Cancer Treatment Decision Making Among Cancer Survivors: Weighing Cancer Recurrence Versus Cardiotoxicity},
  journal = {Psycho-Oncology},
  year = {2025},
  doi = {10.1002/pon.70061}
}
Kostenlos starten →